Company: OPGN
Filing Date: 2025-10-31
Form Type: 10-Q
Source: 0001829126-25-008771
Chunk: 17

Company: OPGEN INC
Filing Date: 2025-10-31
Form: 10-Q
Item: Part I, Item 1
Chunk 17
---
 weighted average shares outstanding

    10,071,286

    1,340,285

    10,071,286

    1,340,285

    Dilutive effect of stock purchase warrants

    55,424

    -

    Dilutive effect of restricted stock units

    40,857

    -

    Dilutive weighted average shares outstanding

    10,167,567

    1,340,285

    Earnings (loss) per share
     
    $
    0.35

    $
    (1.18
    )
     
    $
    0.34

    $
    (1.18
    )

    Basic  
    Diluted 

    Six months ended 
June 30,  
    Six months ended
 June 30, 

    2025  
    2024  
    2025  
    2024 
  
    Net income (loss) 
    $3,101,859  
    $(1,288,382) 
    $3,101,859  
    $(1,288,382)
  
    Net income allocated to preferred stock 
     (18,705) 
     -  
     - 
     - 
  
    Net income (loss) available to common stockholders 
    $3,083,154  
    $(1,288,382) 
    $3,101,859  
    $(1,288,382)

    Basic weighted average shares outstanding 
     10,071,183  
     1,312,544  
     10,071,183  
     1,312,544 
  
    Dilutive effect of preferred stock  

     61,100  
     - 
  
    Dilutive effect of restricted stock units 

     75,659  
     - 
  
    Dilutive weighted average shares outstanding 

     10,207,942  
     1,312,544 

    Earnings (loss) per share 
    $0.31  
    $(0.98) 
    $0.30  
    $(0.98)

None of the potential dilutive securities had
a dilutive impact during the three and six months ended June 30, 2024 due to the Company’s net loss.

The number of anti-dilutive shares for